Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 241547, 11 pages
http://dx.doi.org/10.1155/2015/241547
Review Article

Pregnancy Associated with Systemic Lupus Erythematosus: Immune Tolerance in Pregnancy and Its Deficiency in Systemic Lupus Erythematosus—An Immunological Dilemma

1Division of Nephrology, University of Medicine and Pharmacy “V. Babes” Timisoara, Calea Alexandru Ioan Cuza No. 8 Ap. 16, 300088 Timisoara, Romania
2Division of Nephrology, Emergency County Clinical Hospital Timisoara, Romanian Academy of Medical Sciences, Romania
3Division of Nephrology, University of Medicine and Pharmacy “V. Babes” Timisoara, Emergency County Clinical Hospital Timisoara, Romania
4Department of Obstetrics and Gynecology, University of Medicine and Pharmacy “V. Babes” Timisoara, Emergency County Clinical Hospital Timisoara, Romania

Received 19 September 2014; Revised 5 February 2015; Accepted 6 February 2015

Academic Editor: Clelia M. Riera

Copyright © 2015 Cristina Gluhovschi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. R. Aluvihare, M. Kallikourdis, and A. G. Betz, “Regulatory T cells mediate maternal tolerance to the fetus,” Nature Immunology, vol. 5, no. 3, pp. 266–271, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Mor and I. Cardenas, “The immune system in pregnancy—a unique complexity,” The American Journal of Reproductive Immunology, vol. 63, no. 6, pp. 425–433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Kassi and P. Moutsatsou, “Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 317452, 14 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. E. Munoz, U. S. Gaipl, G. L. Grossmayer et al., “Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 60, no. 6, pp. 1733–1742, 2009. View at Publisher · View at Google Scholar
  5. J. Ernerudh, G. Berg, and J. Mjösberg, “Regulatory T helper cells in pregnancy and their roles in systemic versus local immune tolerance,” The American Journal of Reproductive Immunology, vol. 66, supplement 1, pp. 31–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. N. Baer, F. R. Witter, and M. Petri, “Lupus and pregnancy,” Obstetrical and Gynecological Survey, vol. 66, no. 10, pp. 639–653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Saito, A. Nakashima, T. Shima, and M. Ito, “Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy,” American Journal of Reproductive Immunology, vol. 63, no. 6, pp. 601–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. E. V. Lourenço and A. La Cava, “Natural regulatory T cells in autoimmunity,” Autoimmunity, vol. 44, no. 1, pp. 33–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Kuhn, S. Beissert, and P. H. Krammer, “CD4+CD25+ regulatory T cells in human lupus erythematosus,” Archives of Dermatological Research, vol. 301, no. 1, pp. 71–81, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Maggi, L. Cosmi, F. Liotta, P. Romagnani, S. Romagnani, and F. Annunziato, “Thymic regulatory T cells,” Autoimmunity Reviews, vol. 4, no. 8, pp. 579–586, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Tower, I. Crocker, D. Chirico, P. Baker, and I. Bruce, “SLE and pregnancy: the potential role for regulatory T cells,” Nature Reviews Rheumatology, vol. 7, no. 2, pp. 124–128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. A. Horwitz, “Identity of mysterious CD4+CD25-Foxp3+ cells in SLE,” Arthritis Research & Therapy, vol. 12, no. 1, article 110, 2010. View at Google Scholar · View at Scopus
  13. S. Varghese, I. Crocker, I. N. Bruce, and C. Tower, “Systemic lupus erythematosus, regulatory T cells and pregnancy,” Expert Review of Clinical Immunology, vol. 7, no. 5, pp. 635–648, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Bettelli, T. Korn, and V. K. Kuchroo, “Th17: the third member of the effector T cell trilogy,” Current Opinion in Immunology, vol. 19, no. 6, pp. 652–657, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Korn, E. Betelli, M. Oukka, and V. K. Kichroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar
  16. B. Fu, Z. Tian, and H. Wei, “Th17 cells in human recurrent pregnancy loss and pre-eclampsia,” Cellular & Molecular Immunology, vol. 11, no. 6, pp. 564–570, 2014. View at Publisher · View at Google Scholar
  17. Y. K. Lee, R. Mukasa, R. A. Matton, and C. T. Weaver, “Developmental plasticity of Th17 and Treg cells,” Current Opinion in Immunology, vol. 21, no. 3, pp. 274–280, 2009. View at Publisher · View at Google Scholar
  18. M. Torricelli, F. Bellisai, R. Novembri et al., “High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus,” The American Journal of Reproductive Immunology, vol. 66, no. 2, pp. 84–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Khan, R. Dai, E. Karpuzoglu, and S. A. Ahmed, “Estrogen increases, whereas IL-27 and IFN-γ decrease, splenocyte IL-17 production in WT mice,” European Journal of Immunology, vol. 40, no. 9, pp. 2549–2556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Polese, V. Gridelet, E. Araklioti, H. Martens, S. Perrier d'Hauterive, and V. Geenen, “The endocrine milieu and CD4 T-lymphocyte polarization during pregnancy,” Frontiers in Endocrinology, vol. 5, article 106, 2014. View at Publisher · View at Google Scholar
  21. A. M. Tyagi, K. Srivastava, M. N. Mansoori, R. Trivedi, N. Chattopadhyay, and D. Singh, “Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis,” PLoS ONE, vol. 7, no. 9, Article ID e44552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Nakashima, M. Ito, T. Shima, N. D. Bac, T. Hidaka, and S. Saito, “Accumulation of IL-17-positive cells in decidua of inevitable abortion cases,” American Journal of Reproductive Immunology, vol. 64, no. 1, pp. 4–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-S. Liu, L. Wu, X.-H. Tong et al., “Study on the relationship between Th17 cells and unexplained recurrent spontaneous abortion,” The American Journal of Reproductive Immunology, vol. 65, no. 5, pp. 503–511, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Tsur, G. C. Hughes, Y. Shoenfeld, and H. Carp, “Interdisciplinary exchange of ideas: progestagens for autoimmunity, biologics for pregnancy complications,” Immunologic Research, vol. 61, no. 1-2, pp. 31–34, 2015. View at Publisher · View at Google Scholar
  25. S. Lasarte, D. Elsner, M. Guía-González et al., “Female sex hormones regulate the Th17 immune response to sperm and Candida albicans,” Human Reproduction, vol. 28, no. 12, pp. 3283–3291, 2013. View at Publisher · View at Google Scholar
  26. F. Fettke, A. Schumacher, S. D. Costa, and A. C. Zenclussen, “B cells: the old new player in reproductive immunology,” Frontiers in Immunology, vol. 23, no. 5, article 285, 2014. View at Google Scholar
  27. D. Aït-Azzouzene, M.-C. Gendron, M. Houdayer et al., “Maternal B lymphocytes specific for paternal histocompatibility antigens are partially deleted during pregnancy,” Journal of Immunology, vol. 161, no. 6, pp. 2677–2683, 1998. View at Google Scholar · View at Scopus
  28. J. Anolik, I. Sanz, and R. J. Looney, “B cell depletion therapy in systemic lupus erythematosus,” Current Rheumatology Reports, vol. 5, no. 5, pp. 350–356, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Muzzio, A. C. Zenclussen, and F. Jensen, “The role of B cells in pregnancy: the good and the bad,” The American Journal of Reproductive Immunology, vol. 69, no. 4, pp. 408–412, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. S. R. Sangle, P. M. K. Lutalo, R. J. Davies, M. A. Khamashta, and D. P. D'Cruz, “B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases,” Journal of Autoimmunity, vol. 43, pp. 55–59, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Maidhof and O. Hilas, “Lupus: an overview of the disease and management options,” Pharmacy and Therapeutics, vol. 37, no. 4, pp. 240–246, 2012. View at Google Scholar · View at Scopus
  32. J. P. Buyon and R. M. Clancy, “Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach,” Seminars in Arthritis and Rheumatism, vol. 33, no. 3, pp. 140–154, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Ulcova-Gallova, A. Mockova, and M. Cedikova, “Screening tests of reproductive immunology in systemic lupus erythematosus,” Autoimmune Diseases, vol. 2012, Article ID 812138, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Tincani, D. Bompane, E. Danieli, and A. Doria, “Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome),” Lupus, vol. 15, no. 3, pp. 156–160, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Le Thi Thuong, N. Tieulié, N. Costedoat et al., “The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 in 15 women,” Annals of the Rheumatic Diseases, vol. 64, no. 2, pp. 273–278, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. D. Lockshin, M. L. Druzin, S. Goei et al., “Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus,” The New England Journal of Medicine, vol. 313, no. 3, pp. 152–156, 1985. View at Publisher · View at Google Scholar · View at Scopus
  37. H. P. McNeil, C. N. Chesterman, and S. A. Krilis, “Immunology and clinical importance of antiphospholipid antibodies,” Advances in Immunology, vol. 49, pp. 193–280, 1991. View at Publisher · View at Google Scholar · View at Scopus
  38. J. P. Hayslett, “The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome,” American Journal of Reproductive Immunology, vol. 28, no. 3-4, pp. 199–204, 1992. View at Publisher · View at Google Scholar · View at Scopus
  39. D. W. Branch, A. M. Peaceman, M. Druzin et al., “A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy,” The American Journal of Obstetrics and Gynecology, vol. 182, no. 1 I, pp. 122–127, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Koyasu and K. Moro, “Role of innate lymphocytes in infection and inflammation,” Frontiers in Immunology, vol. 3, article 101, 2012. View at Publisher · View at Google Scholar
  41. T.-J. Kim, V. Upadhyay, V. Kumar, K.-M. Lee, and Y.-X. Fu, “Innate lymphoid cells facilitate NK development through a lymphotoxin-mediated stromal microenvironment,” Journal of Experimental Medicine, vol. 211, no. 7, pp. 1421–1431, 2014. View at Publisher · View at Google Scholar
  42. A. Poggi and M. R. Zocchi, “NK cell autoreactivity and autoimmune diseases,” Frontiers in Immunology, vol. 5, article 27, 2014. View at Publisher · View at Google Scholar
  43. A. C. Pereira, M. C. B. dos Santos Lima, N. R. de Jesús, M. M. França, H. da Silva Nahum Jr., and R. A. Levy, “NK cells in pregnant patients with SLE: a preliminary study,” Revista Brasileira de Reumatologia, vol. 49, no. 4, pp. 387–401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. A. G. Baxter and M. J. Smyth, “The role of NK cells in autoimmune disease,” Autoimmunity, vol. 35, no. 1, pp. 1–14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Su, S. Hong, and A. Zhao, “The changes of T lymphocyte subsets and serum interleukin-2 receptor in peripheral blood of the pregnant women complicated by systemic lupus erythematosus,” Zhonghua Fu Chan Ke Za Zhi, vol. 32, no. 11, pp. 671–673, 1997. View at Google Scholar · View at Scopus
  46. L. Lunghi, B. Pavan, C. Biondi et al., “Use of glucocorticoids in pregnancy,” Current Pharmaceutical Design, vol. 16, no. 32, pp. 3616–3637, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. C.-C. Yeh, K.-C. Chao, and S. J. Huang, “Innate immunity, decidual cells, and preeclampsia,” Reproductive Sciences, vol. 20, no. 4, pp. 339–353, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. I. Manaster and O. Mandelboim, “The unique properties of human NK cells in the uterine mucosa,” Placenta, vol. 29, pp. 60–66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. I. T. González, G. Barrientos, N. Freitag et al., “Uterine NK cells are critical in shaping DC immunogenic function compatible with pregnancy progression,” PLoS ONE, vol. 7, no. 10, Article ID e46755, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Wallace, G. S. Whitley, B. Thilaganathan, and J. E. Corturight, “Decidual natural killer cell receptor expression is altered in pregnancies with impaired vascular remodeling and a higher risk of pre-eclampsia,” Journal of Leukocyte Biology, vol. 97, no. 1, pp. 79–86, 2015. View at Publisher · View at Google Scholar
  51. M. D. Hazenberg and H. Spits, “Human innate lymphoid cells,” Blood, vol. 124, no. 5, pp. 700–709, 2014. View at Publisher · View at Google Scholar
  52. M. Cherrier and G. Eberl, “The development of LTi cells,” Current Opinion in Immunology, vol. 24, no. 2, pp. 178–183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Vacca, E. Montaldo, D. Croxatto et al., “Identification of diverse innate lymphoid cells in human decidua,” Mucosal Immunology, vol. 8, no. 2, pp. 254–264, 2015. View at Publisher · View at Google Scholar
  54. K. D. Heyborne, R. L. Cranfill, S. R. Carding, W. K. Born, and R. L. O'Brien, “Characterization of γδ T lymphocytes at the maternal-fetal interface,” Journal of Immunology, vol. 149, no. 9, pp. 2872–2878, 1992. View at Google Scholar · View at Scopus
  55. J. Szekeres-Bartho, A. Barakonyi, B. Polgar et al., “The role of γ/δ T cells in progesterone-mediated immunomodulation during pregnancy: a review,” American Journal of Reproductive Immunology, vol. 42, no. 1, pp. 44–48, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Polgar, A. Barakonyi, I. Xynos, and J. Szekeres-Bartho, “The role of γ/δ T cell receptor positive cells in pregnancy,” The American Journal of Reproductive Immunology, vol. 41, no. 4, pp. 239–244, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Su, M. Shen, X. Li, and L. Sun, “Roles of gamma/delta T cells in pathogenesis of autoimmune diseases,” Clinical and Developmental Immunology, vol. 2013, Article ID 985753, 6 pages, 2013. View at Publisher · View at Google Scholar
  58. T. Fujii, M. Okada, and J. Craft, “Regulation of T cell-dependent autoantibody production by a γδ T cell line derived from lupus-prone mice,” Cellular Immunology, vol. 217, no. 1-2, pp. 23–35, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Björkander, G. Heidari-Hamedani, K. Bremme, I. Gunnarsson, and U. Holmlund, “Peripheral monocyte expression of the chemokine receptors CCR2, CCR5 and CXCR3 is altered at parturition in healthy Women and in women with systemic lupus erythematosus,” Scandinavian Journal of Immunology, vol. 77, no. 3, pp. 200–212, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. M. M. Faas, F. Spaans, and P. de Vog, “Monocytes and macrophages in pregnancy and pre-eclampsia,” Frontiers in Immunology, vol. 5, article 298, 2014. View at Publisher · View at Google Scholar
  61. A. K. Palucka, J. Banchereau, P. Blanco, and V. Pascual, “The interplay of dendritic cell subsets in systemic lupus erythematosus,” Immunology and Cell Biology, vol. 80, no. 5, pp. 484–488, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Tagliani and A. Erlebacher, “Dendritic cell function at the maternal-fetal interface,” Expert Review of Clinical Immunology, vol. 7, no. 5, pp. 593–602, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. J. H. Fransen, J. V. D. Vlag, J. Ruben, G. J. Adema, J. H. Berden, and L. B. Hilbrands, “The role of dendritic cells in the pathogenesis of systemic lupus erythematosus,” Arthritis Research and Therapy, vol. 12, no. 2, article 207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. L. J. Jara, G. T. Romero-Sanchez, L. A. Montiel-Cervantes et al., “Dendritic cells and regulatory T CD4CD25Bright in pregnant patients with systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 62, supplement 10, p. 1150, 2010. View at Publisher · View at Google Scholar
  65. F. Tanriverdi, L. F. G. Silveira, G. S. MacColl, and P. M. G. Bouloux, “The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity,” Journal of Endocrinology, vol. 176, no. 3, pp. 293–304, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Cutolo, A. Sulli, B. Seriolo, S. Accardo, and A. T. Masi, “Estrogens, the immune response and autoimmunity,” Clinical and Experimental Rheumatology, vol. 13, no. 2, pp. 217–226, 1995. View at Google Scholar · View at Scopus
  67. A. Doria, L. Iaccarino, P. Sarzi-Puttini et al., “Estrogens in pregnancy and systemic lupus erythematosus,” Annals of the New York Academy of Sciences, vol. 1069, pp. 247–256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. L. Iaccarino, A. Ghirardello, M. Zen et al., “Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus,” Reumatismo, vol. 64, no. 5, pp. 314–320, 2012. View at Google Scholar · View at Scopus
  69. N. Kanda, T. Tsuchida, and K. Tamaki, “Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 42, no. 2, pp. 328–337, 1999. View at Google Scholar
  70. J. F. G. Cohen-Solal, V. Jeganathan, L. Hill et al., “Hormonal regulation of B-cell function and systemic lupus erythematosus,” Lupus, vol. 17, no. 6, pp. 528–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Zen, A. Ghirardello, L. Iaccarino et al., “Hormones, immune response, and pregnancy in healthy women and SLE patients,” Swiss Medical Weekly, vol. 140, no. 13-14, pp. 187–201, 2010. View at Google Scholar · View at Scopus
  72. G. C. Hughes and D. Choubey, “Modulation of autoimmune rheumatic diseases by oestrogen and progesterone,” Nature Reviews Rheumatology, vol. 10, pp. 740–751, 2014. View at Publisher · View at Google Scholar
  73. M.-R. Du, S.-C. Wang, and D.-J. Li, “The integrative roles of chemokines at the maternal-fetal interface in early pregnancy,” Cellular and Molecular Immunology, vol. 11, no. 5, pp. 438–448, 2014. View at Publisher · View at Google Scholar
  74. A. Blaschitz, H. Hutter, and G. Dohr, “HLA Class I protein expression in the human placenta,” Early Pregnancy, vol. 5, no. 1, pp. 67–69, 2001. View at Google Scholar
  75. M. D. Lockshin and L. R. Sammaritano, “Lupus pregnancy,” Autoimmunity, vol. 36, no. 1, pp. 33–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Nayar and J. M. Lage, “Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome: a case report and review of the literature,” Human Pathology, vol. 27, no. 2, pp. 201–206, 1996. View at Publisher · View at Google Scholar · View at Scopus
  77. J. G. Hanly, D. D. Gladman, T. H. Rose, C. A. Laskin, and M. B. Urowitz, “Lupus pregnancy. A prospective study of placental changes,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 358–366, 1988. View at Publisher · View at Google Scholar · View at Scopus
  78. J. P. Hayslett, “Maternal and fetal complications in pregnant women with systemic lupus erythematosus,” American Journal of Kidney Diseases, vol. 17, no. 2, pp. 123–126, 1991. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Melk, G. Mueller-Eckhardt, B. Polten, A. Lattermann, O. Heine, and O. Hoffmann, “Diagnostic and prognostic significance of anticardiolipin antibodies in patients with recurrent spontaneous abortions,” The American Journal of Reproductive Immunology, vol. 33, no. 3, pp. 228–233, 1995. View at Publisher · View at Google Scholar · View at Scopus
  80. F. Qureshi, Y. Yang, S. M. Jacques et al., “Anti-DNA antibodies cross-reacting with laminin inhibit trophoblast attachment and migration: implications for recurrent pregnancy loss in SLE patients,” American Journal of Reproductive Immunology, vol. 44, no. 3, pp. 136–142, 2000. View at Publisher · View at Google Scholar · View at Scopus
  81. M. E. B. Clowse, L. S. Magder, F. Witter, and M. Petri, “Early risk factors for pregnancy loss in lupus,” Obstetrics and Gynecology, vol. 107, no. 2, pp. 293–299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. V. Saini, S. Arora, A. Yadav, and J. Bhattacharjee, “Cytokines in recurrent pregnancy loss,” Clinica Chimica Acta, vol. 412, no. 9-10, pp. 702–708, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. K. L. Hon and A. K. C. Leung, “Neonatal lupus erythematosus,” Autoimmune Diseases, vol. 2012, Article ID 301274, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. J. P. Buyon and R. M. Clancy, “Neonatal lupus syndromes,” Current Opinion in Rheumatology, vol. 15, no. 5, pp. 535–541, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Boutjdir, L. Chen, Z.-H. Zhang, C.-E. Tseng, N. El-Sherif, and J. P. Buyon, “Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model,” Pediatric Research, vol. 44, no. 1, pp. 11–19, 1998. View at Publisher · View at Google Scholar · View at Scopus
  86. W. Wisuthsarewong, J. Soongswang, and R. Chantorn, “Neonatal lupus erythematosus: clinical character, investigation, and outcome,” Pediatric Dermatology, vol. 28, no. 2, pp. 115–121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Okawa-Takatsuji, S. Aotsuka, S. Uwatoko et al., “Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases,” Clinical and Experimental Immunology, vol. 126, no. 2, pp. 345–354, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Shahian, A. Khosravi, and M.-H. Anbardar, “Early cholestasis in neonatal lupus erythematosus,” Annals of Saudi Medicine, vol. 31, no. 1, pp. 80–82, 2011. View at Google Scholar · View at Scopus
  89. O. Meyer, “Making pregnancy safer for patients with lupus,” Joint Bone Spine, vol. 71, no. 3, pp. 178–182, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. D. Elish and N. B. Silverberg, “Neonatal lupus erythematosus,” Cutis, vol. 77, no. 2, pp. 82–86, 2006. View at Google Scholar · View at Scopus
  91. J. T. Repke, “Hypertensive disorders of pregnancy. Differentiating preeclampsia from active systemic lupus erythematosus,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 43, no. 4, pp. 350–354, 1998. View at Google Scholar · View at Scopus
  92. A. Perez-Sepulveda, M. J. Torres, M. Khoury, and S. F. Illanes, “Innate immune system and preeclampsia,” Frontiers in Immunology, vol. 5, p. 244, 2014. View at Publisher · View at Google Scholar
  93. A. Fatemi, R. M. Fard, Z. Sayedbonakdar, Z. Farajzadegan, and M. Saber, “The role of lupus nephritis in development of adverse maternal and fetal outcomes during pregnancy,” International Journal of Preventive Medicine, vol. 4, no. 9, pp. 1004–1010, 2013. View at Google Scholar · View at Scopus
  94. G. Ruiz-Irastorza, F. Lima, J. Alves et al., “Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies,” British Journal of Rheumatology, vol. 35, no. 2, pp. 133–138, 1996. View at Publisher · View at Google Scholar · View at Scopus